[Prognostic usefulness of clinical and laboratory indicators in patients with advanced forms of non-Hodgkin lymphoma treated by the COP protocol].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D012737:Sex Factors; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone
Przydatność rokownicza wskaźników klinicznych oraz laboratoryjnych u chorych z zaawansowanymi postaciami chłoniaków nie-ziarniczych leczonych wg programu COP.